+1 (629)348-3199Opinion Article - Journal of Gastroenterology and Digestive Diseases (2023) Volume 8, Issue 1
Epigastria hiatus hernia and gastroesophageal reflux disease.
Among patients without warning symptoms, the treatment of Gastroesophageal Reflux Disease (GERD) frequently begins with an empiric trial of Proton Pump Inhibitor (PPI) therapy and additional lifestyle changes. Persistent symptoms can be reduced by optimising therapy (better compliance and timing of PPI doses), or in some cases, by increasing PPI dosage to twice daily. Endoscopy and esophageal physiology tests can be used to assess patients with persistent symptoms in order to better understand their disease profile and tailor their care. Patients with well-defined GERD may benefit from laparoscopic fundoplication, magnetic sphincter augmentation, and endoscopic treatments.
Author(s): Jhon Sophia